I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Tout, Mira
25
results:
Search for persons
X
Format
Online (25)
Mediatypes
Articles (Online) (4)
OpenAccess-fulltext (21)
Sorted by: Relevance
Sorted by: Year
?
1
Dose rationale for the use of meropenem/vaborbactam combina..:
Fornari, Chiara
;
Arrieta, Antonio
;
Bradley, John S.
...
British Journal of Clinical Pharmacology. , 2024
Link:
https://doi.org/10.1111/..
?
2
A possible association of baseline serum IL-17A concentrati..:
Lereclus, Emilie
;
Tout, Mira
;
Girault, Alban
...
BMC Cancer. 17 (2017) 1 - p. , 2017
Link:
https://doi.org/10.1186/..
?
3
Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antig..:
Tout, Mira
;
Gagez, Anne-Laure
;
Leprêtre, Stéphane
...
Clinical Pharmacokinetics. 56 (2016) 6 - p. 635-647 , 2016
Link:
https://doi.org/10.1007/..
?
4
Gota et al. on their article "the pharmacokinetics of Redit..:
Tout, Mira
;
Passot, Christophe
;
Cartron, Guillaume
..
Cancer Chemotherapy and Pharmacology. 78 (2016) 6 - p. 1317-1318 , 2016
Link:
https://doi.org/10.1007/..
?
5
Increased rituximab exposure does not improve response and ..:
Cartron, Guillaume
;
Letestu, Rémi
;
Dartigeas, Caroline
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068027/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
6
Rituximab exposure is influenced by baseline metabolic tumo..:
Tout, Mira
;
Casasnovas, Olivier
;
Meignan, Michel
...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2016-10-744292. , 2017
Link:
https://hal.science/hal-..
?
7
Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antig..:
Tout, Mira
;
Gagez, Anne-Laure
;
Lepretre, Stéphane
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40262-016-0470-8. , 2017
Link:
https://hal.science/hal-..
?
8
Rituximab exposure is influenced by baseline metabolic tumo..:
Tout, Mira
;
Casasnovas, Olivier
;
Meignan, Michel
...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2016-10-744292. , 2017
Link:
https://hal.science/hal-..
?
9
Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antig..:
Tout, Mira
;
Gagez, Anne-Laure
;
Lepretre, Stéphane
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40262-016-0470-8. , 2017
Link:
https://hal.science/hal-..
?
10
Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antig..:
Tout, Mira
;
Gagez, Anne-Laure
;
Lepretre, Stéphane
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40262-016-0470-8. , 2017
Link:
https://hal.science/hal-..
?
11
Rituximab exposure is influenced by baseline metabolic tumo..:
Tout, Mira
;
Casasnovas, Olivier
;
Meignan, Michel
...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2016-10-744292. , 2017
Link:
https://hal.science/hal-..
?
12
Rituximab exposure is influenced by baseline metabolic tumo..:
Tout, Mira
;
Casasnovas, Olivier
;
Meignan, Michel
...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2016-10-744292. , 2017
Link:
https://hal.science/hal-..
?
13
Rituximab exposure is influenced by baseline metabolic tumo..:
Tout, Mira
;
Casasnovas, Olivier
;
Meignan, Michel
...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2016-10-744292. , 2017
Link:
https://hal.science/hal-..
?
14
Rituximab exposure is influenced by baseline metabolic tumo..:
Tout, Mira
;
Casasnovas, Olivier
;
Meignan, Michel
...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2016-10-744292. , 2017
Link:
https://hal.science/hal-..
?
15
Rituximab exposure is influenced by baseline metabolic tumo..:
Tout, Mira
;
Casasnovas, Olivier
;
Meignan, Michel
...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2016-10-744292. , 2017
Link:
https://hal.science/hal-..
1-15
